Overview

Compassionate Use of Omegaven IV Fat Emulsion

Status:
Terminated
Trial end date:
2014-02-01
Target enrollment:
Participant gender:
Summary
This is a compassionate use protocol to use intravenous fish oil infusion, Omegaven®, to infants and children with parenteral nutrition-associated liver disease to enable reversal of elevated serum liver enzymes and direct bilirubin (cholestasis).
Phase:
Phase 2
Details
Lead Sponsor:
Cindy Haller